We are monitoring the impact of COVID-19 on APAC Spine Biologics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 4121
Share on
Share on

Asia Pacific Spine Biologics Market Research Report - Segmented By Product Type, By Surgery Type & By Country(India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends And Forecasts(2019-2024)

Pulished: February, 2020
ID: 4121
Pages: 130

APAC Spine Biologics Market Size & Growth (2019 – 2024)

As per the research report, the size of the Asia Pacific Spine Biologics Market is valued at USD 450 million in 2019 and estimated to be growing at a CAGR of 4.9%, to reach USD 570 million by 2024 during the forecast period 2019-2024.

Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such as trauma, tumors, degenerative disc disease, and spinal cord injuries by stimulating bone growth formation through the inflammatory stage, repair stage, and remodeling stage. Biologics help in faster recovery and activate cellular growth. Therefore, the surge in the number of spinal fusion surgeries has fueled the adoption of biologics.

Spine Biologics market is growing due to advancement in technology as well as demand for better minimally surgical procedures, which make it more convenient for both the patient and doctor. Factors such as a rise in the prevalence of diseases due to the aging population and increased government funding are also driving the overall market. The major factors restraining the growth of the market are the high healthcare costs for such procedures, lack of expert professionals and unfavorable reimbursement scenarios.

This research report segmented and sub-segmented into the following categories:

  • By Product Type: platelet Rich Plasma, Bone Graft, Bone Graft Substitutes And Bone Marrow Aspirate Therapy
  • By Surgery Type: Transforaminal Lumbar Interbody Fusion, Anterior Lumbar Interbody Fusion, Lateral Lumbar Interbody Fusion, Anterior Cervical Discectomy And Fusion, Posterior Lumbar Interbody Fusion, Others
  • By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC

Improving healthcare infrastructure and an increase in expenditures in the emerging markets, such as India and China, to cater to the unmet medical needs in these countries have bolstered the market growth.

The Top companies leading in the APAC Spine Biologics Market profiled in the report are Alphatec Holdings, Inc., Depuy Synthes (Johnson & Johnson), Exactech, Inc., Globus Medical, Inc., Medtronic plc, NuVasive, Inc., Orthofix International N.V., RTI Surgical, Inc., SeaSpine, and Zimmer Biomet Holdings, Inc.

1. Introduction   

                1.1 Market Definition     

                1.2 Study Deliverables   

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions 

2. Research Methodology             

                2.1 Introduction 

                2.2 Research Phases       

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design          

                2.4 Study Timeline           

3. Overview         

                3.1 Executive Summary 

                3.2 Key Inferences          

                3.3 Epidemology

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)      

                4.1 Market Drivers           

                4.2 Market Restraints     

                4.3 Key Challenges          

                4.4 Current Opportunities in the Market

5. Market Segmentation                

                5.1 Surgery type

                                5.1.1 Introduction                                           

                                5.1.2 Anterior Cervical Discectomy and Fusion                                   

                                5.1.3 Posterior Lumbar Interbody Fusion                                              

                                5.1.4 Transforaminal Lumbar Interbody Fusion                                  

                                5.1.5 Anterior Lumbar Interbody Fusion                               

                                5.1.6 Lateral Lumbar Interbody Fusion                                   

                                5.1.7 Others                                      

                                5.1.8  Y-o-Y Growth Analysis, By surgery type                                     

                                5.1.9  Market Attractiveness Analysis, By surgery type                                   

                                5.1.10 Market Share Analysis, By surgery type                                   

                5.2 Product type

                                5.2.1 Introduction                                           

                                5.2.2 Bone graft

5.2.2.1 Autograft                             

5.2.2.2 Allograft               

                                5.2.3 Bone graft substitutes                                       

5.2.3.1 Synthetic bone grafts                     

5.2.3.2 Demineralized bone matrix                          

5.2.3.3 Bone Morphogenetic proteins                   

                                5.2.4 Platelet rich plasma                                             

                                5.2.5 Bone marrow aspitaye therapy                                      

                                5.2.6 Y-o-Y Growth Analysis, By Product type                                     

                                5.2.7 Market Attractiveness Analysis, By Product type                                   

                                5.2.8 Market Share Analysis, By Product type                                     

6. Geographical Analysis                

                6.1 Introduction 

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

6.1.3.1 By Geographical Area                     

6.1.3.2 By Surgery type                 

6.1.3.3 By Product Type                

                                6.1.4  Market Attractiveness Analysis                                     

6.1.4.1 By Geographical Area                     

6.1.4.2 By Surgery type                 

6.1.4.3 By Product Type                

                                6.1.5  Market Share Analysis                                      

6.1.5.1 By Geographical Area                     

6.1.5.2 By Surgery type                 

6.1.5.3 By Product Type                

                6.2 China              

                6.3 India               

                6.4 Japan             

                6.5 South Korea 

                6.6 Australia       

7. Strategic Analysis         

                7.1 PESTLE analysis          

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis          

                8.1  Alphatec Holdings Inc.           

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Depuy Synthes          

                8.3 Exactech Inc.

                8.4 Globus Medical Inc. 

                8.5 Medtronic plc.            

                8.6 NuVasive Inc.             

                8.7 Orthofix International N.V.   

                8.8 RTI Surgical Inc.          

                8.9 SeaSpine      

                8.10 Zimmer Biomet Holdings Inc.             

9. Competitive Landscape             

                9.1 Market share analysis             

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10. Market Outlook and Investment Opportunities           

Appendix             

                a) List of Tables 

                b) List of Figures

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of surgery type and product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the Asia Pacific Market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia Pacific Spine Biologics Market By Surgery type, From 2018-2023 ( USD Billion )
  2. Asia Pacific Anterior Cervical Discectomy and Fusion Market By Region, From 2018-2023 ( USD Billion )
  3. Asia Pacific Posterior Lumbar Interbody Fusion Market By Region, From 2018-2023 ( USD Billion )
  4. Asia Pacific Transforaminal Lumbar Interbody Fusion Market By Region, From 2018-2023 ( USD Billion )
  5. Asia Pacific Anterior Lumbar Interbody Fusion Market By Region, From 2018-2023 ( USD Billion )
  6. Asia Pacific Lateral Lumbar Interbody Fusion Market By Region, From 2018-2023 ( USD Billion )
  7. Asia Pacific Others Market By Region, From 2018-2023 ( USD Billion )
  8. Asia Pacific Spine Biologics Market By Product type, From 2018-2023 ( USD Billion )
  9. Asia Pacific Bone graft Market By Region, From 2018-2023 ( USD Billion )
  10. Asia Pacific Bone graft substitutes Market By Region, From 2018-2023 ( USD Billion )
  11. Asia Pacific Platelet rich plasma Market By Region, From 2018-2023 ( USD Billion )
  12. Asia Pacific Bone marrow aspirate therapy Market By Region, From 2018-2023 ( USD Billion )
  13. Japan Spine Biologics Market By Surgery type, From 2018-2023 ( USD Billion )
  14. Japan Spine Biologics Market By Product type, From 2018-2023 ( USD Billion )
  15. China Spine Biologics Market By Surgery type, From 2018-2023 ( USD Billion )
  16. China Spine Biologics Market By Product type, From 2018-2023 ( USD Billion )
  17. India Spine Biologics Market By Surgery type, From 2018-2023 ( USD Billion )
  18. India Spine Biologics Market By Product type, From 2018-2023 ( USD Billion )
  19. Australia Spine Biologics Market By Surgery type, From 2018-2023 ( USD Billion )
  20. Australia Spine Biologics Market By Product type, From 2018-2023 ( USD Billion )
  21. South Korea Spine Biologics Market By Surgery type, From 2018-2023 ( USD Billion )
  22. South Korea Spine Biologics Market By Product type, From 2018-2023 ( USD Billion )
  23. Asia Pacific Spine Biologics Market By Bone graft, From 2018-2023 ( USD Billion )
  24. Asia Pacific Allograft Market By Region, From 2018-2023 ( USD Billion )
  25. Asia Pacific Autograft Market By Region, From 2018-2023 ( USD Billion )
  26. Japan Spine Biologics Market By Bone graft, From 2018-2023 ( USD Billion )
  27. China Spine Biologics Market By Bone graft, From 2018-2023 ( USD Billion )
  28. India Spine Biologics Market By Bone graft, From 2018-2023 ( USD Billion )
  29. Australia Spine Biologics Market By Bone graft, From 2018-2023 ( USD Billion )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample